Humasis Supplies COVID-19 Diagnostic Kits to Brazil with KOTRA Support

[Asia Economy Reporter Hyunseok Yoo] Humasis has signed an import contract for the novel coronavirus infection (COVID-19) antibody rapid diagnostic kit product ‘COVID-19 IgG/IgM Test’ with a supplier in Brazil, the company announced on the 6th. The company had previously obtained export approval for the diagnostic kit product from the Ministry of Food and Drug Safety on the 27th of last month.

With this contract, Humasis became the first diagnostic company to supply Korean-made diagnostic kits to the Brazilian market. Accordingly, starting with the first shipment this month, a total of 1 million test units of COVID-19 diagnostic kits will be exported to Brazil.

In particular, the success of this contract was supported by the Korea Trade-Investment Promotion Agency (KOTRA). KOTRA S?o Paulo, active in Brazil, has been connecting Brazilian buyers belonging to private research institutes, state governments, and local governments with domestic diagnostic companies.

Humasis plans to supply COVID-19 diagnostic kits not only to Brazil but also to European countries such as Italy and Germany, as well as Indonesia, Canada, the Middle East, and Africa. The number of overseas countries that have already requested COVID-19 diagnostic kits from Humasis has reached about 30.

The company estimates the total quantity requested by these countries to be about 3 million test units and has switched to an emergency production system to meet this demand. In particular, having introduced new fully automated equipment necessary for diagnostic kit production earlier this year, capable of producing up to 2.5 million test units per month, the company believes there will be no significant difficulty in supplying primarily the requested quantities.

Cha Jung-hak, CEO of Humasis, said, “We hope that the export of this diagnostic kit will help in some way with Brazil’s COVID-19 response,” and added, “As inquiries from government departments of Brazil and other countries are pouring in, we expect export volumes to increase in the future. Therefore, we plan to increase production and prioritize supply to countries where export procedures and registration processes have been completed.”

Meanwhile, established in June 2000, Humasis is a company leading the diagnostic market, having manufactured Korea’s first influenza test product. Humasis’s COVID-19 antibody diagnostic kit, ‘COVID-19 IgG/IgM Test,’ can be used with only 10uL (about one drop) of blood from plasma, serum, whole blood, or capillary blood.

This content was produced with the assistance of AI translation services.